Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited

BMC Infectious Diseases
Pernille MartensThomas Benfield

Abstract

Invasive infection with Streptococcus pneumoniae (pneumococci) causes significant morbidity and mortality. Case series and experimental data have shown that the capsular serotype is involved in the pathogenesis and a determinant of disease outcome. Retrospective review of 464 cases of invasive disease among adults diagnosed between 1990 and 2001. Multivariate Cox proportional hazard analysis. After adjustment for other markers of disease severity, we found that infection with serotype 3 was associated with an increased relative risk (RR) of death of 2.54 (95% confidence interval (CI): 1.22-5.27), whereas infection with serotype 1 was associated with a decreased risk of death (RR 0.23 (95% CI, 0.06-0.97)). Additionally, older age, relative leucopenia and relative hypothermia were independent predictors of mortality. Our study shows that capsular serotypes independently influenced the outcome from invasive pneumococcal disease. The limitations of the current polysaccharide pneumococcal vaccine warrant the development of alternative vaccines. We suggest that the virulence of pneumococcal serotypes should be considered in the design of novel vaccines.

References

Nov 21, 1991·The New England Journal of Medicine·E D ShapiroJ D Clemens
Aug 1, 1989·Infection and Immunity·A M BerryJ C Paton
May 1, 1988·Annals of Internal Medicine·R V SimsJ S Schwartz
Feb 16, 1985·British Medical Journal·W R GransdenI Phillips
Sep 1, 1974·Archives of Internal Medicine·M A MufsonW I Metzger
Feb 25, 1983·JAMA : the Journal of the American Medical Association·E W HookD R Schaberg
Aug 1, 1980·The Journal of Infectious Diseases·J C GuckianD P Fine
Feb 1, 1996·Infection and Immunity·J R de los ToyosT J Mitchell
Aug 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B AfessaW R Frederick
Jan 17, 1996·JAMA : the Journal of the American Medical Association·J F PlouffeR R Facklam
Apr 3, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P PastorT V Murphy
Aug 18, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R J Stanek, M A Mufson
Aug 19, 2000·The Journal of Infectious Diseases·B HenriquesG Källenius
Apr 13, 2001·JAMA : the Journal of the American Medical Association·K A RobinsonUNKNOWN Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network
Aug 21, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J F MoroneyA Schuchat
Mar 5, 2002·Clinical and Diagnostic Laboratory Immunology·Helle Bossen Konradsen, Margit Staum Kaltoft
May 2, 2003·The New England Journal of Medicine·Cynthia G WhitneyUNKNOWN Active Bacterial Core Surveillance of the Emerging Infections Program Network
May 2, 2003·The New England Journal of Medicine·Lisa A JacksonUNKNOWN Vaccine Safety Datalink
May 1, 1964·Annals of Internal Medicine·R AUSTRIAN, J GOLD
Oct 3, 2003·The New England Journal of Medicine·Keith P KlugmanUNKNOWN Vaccine Trialists Group
Jul 1, 1949·The Journal of Experimental Medicine·W B WOOD, M R SMITH

❮ Previous
Next ❯

Citations

Jun 8, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S R J AlaneeUNKNOWN International Pneumococcal Study Group
Jun 8, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Javier Garau, Esther Calbo
Aug 12, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marc G RomneyPatricia Daly
Aug 19, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Daniel M WeinbergerMarc Lipsitch
Jan 1, 2009·The Pediatric Infectious Disease Journal·Simon RückingerMark van der Linden
Jan 5, 2006·Journal of Clinical Microbiology·Lea-Ann S KirkhamTim J Mitchell
Dec 15, 2010·International Journal of Microbiology·Donald InverarityGiles Edwards
Jan 27, 2016·Emerging Infectious Diseases·Claire von MollendorfUNKNOWN Group for Enteric, Respiratory, and Meningeal Disease Surveillance in South Africa (GERMS-SA)
Jan 9, 2013·Human Vaccines & Immunotherapeutics·Pilar CiruelaAngela Domínguez
Feb 20, 2015·Emerging Infectious Diseases·Adoración Navarro-TornéUNKNOWN Invasive Pneumococcal Disease Study Group
Apr 22, 2011·Primary Care Respiratory Journal : Journal of the General Practice Airways Group·Victoria FurerGabriel Izbicki
Sep 15, 2007·FEMS Immunology and Medical Microbiology·Ricardo Dias, Manuela Caniça
Dec 17, 2008·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·I-Shiow JanLi-Na Lee
Apr 4, 2017·The Journal of Infectious Diseases·Fadie T ColemanJoseph P Mizgerd
Jun 13, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Godwin OligbuShamez N Ladhani
Feb 24, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Soheila AbachiH P Vasantha Rupasinghe
Sep 14, 2017·Journal of Intensive Care Medicine·Joanna H ZurawskaPeter M Dodek
Nov 27, 2018·PLoS Pathogens·Taj AzarianWilliam P Hanage
Jan 23, 2019·Human Vaccines & Immunotherapeutics·Paeton L Wantuch, Fikri Y Avci
Jan 31, 2019·Human Vaccines & Immunotherapeutics·Koji Kuronuma, Hiroki Takahashi
Dec 3, 2015·Revista chilena de pediatría·Juan Pablo RojasUNKNOWN Grupo de estudio de Enfermedad Neumocócica en Colombia-Neumocolombia
Oct 7, 2005·Expert Review of Anti-infective Therapy·E David G McIntosh
Dec 8, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sarah E WeberLiise-anne Pirofski
Feb 22, 2011·Expert Review of Vaccines·Mark H RozenbaumEelko Hak

❮ Previous
Next ❯

Software Mentioned

SPSS
Statistical Package for Social Sciences

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Meningitis

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Bacterial Meningitis (ASM)

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
S R J AlaneeInternational Pneumococcal Study Group
Advances in Experimental Medicine and Biology
M Shani-SeklerY Mizrachi-Brauner
© 2022 Meta ULC. All rights reserved